SCHEMBL8190011

SCHEMBL8190011

O=CNCC(=O)OCCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.54
HCAR2 Q8TDS4 1/20 0.51
AKR1B10 O60218 2/20 0.49
AKR1B1 P15121 2/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
APP P05067 1/20 0.48
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
LMNA P02545 1/20 0.46
ALOX5 P09917 2/20 0.46
ADH1B P00325 1/20 0.46
ADH1C P00326 1/20 0.46
ADH1A P07327 1/20 0.46
ADH7 P40394 1/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8190924 0.92 LMNA (0.57) TDP1AKR1B10AKR1B1LMNAADH1B
SCHEMBL1085719 0.88 TDP1 (0.51) TDP1HCAR2AKR1B10AKR1B1CA1
SCHEMBL5733972 0.83 ALDH1A1 (0.58) TDP1HCAR2CA1CA2LMNA
SCHEMBL31174370 0.82 CA1 (0.68) TDP1HCAR2AKR1B10AKR1B1CA1
SCHEMBL451184 0.81 TDP1 (0.68) TDP1HCAR2AKR1B10AKR1B1APP
SCHEMBL31174369 0.81 CA1 (0.55) TDP1HCAR2AKR1B10AKR1B1CA1
SCHEMBL28830827 0.79 TDP1 (0.66) TDP1HCAR2AKR1B10AKR1B1APP
SCHEMBL28656076 0.78 LMNA (0.44) TDP1CA1CA2LMNAADH1B
SCHEMBL28040152 0.78 TDP1 (0.59) TDP1HCAR2AKR1B10AKR1B1APP
SCHEMBL451185 0.78 TDP1 (0.63) TDP1HCAR2AKR1B10AKR1B1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6140338-A FOR TREATING ACUTE INFLAMMATORY DISEASES, CHRONIC INFLAMMATORY DISEASES, ACQUIRED IMMUNE DEFICIENCY SYNDROME, CANCER, ISCHEMIC REFLOW DISORDER AND/OR ARTERIOSCLEROSIS BANYU PHARMACEUTICAL, CO., LTD. (JP) 2000-10-31 US disclosed
EP-0916668-A1 CHEMOKINE RECEPTOR ANTAGONISTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-05-19 EP disclosed